Latest News

First, marijuana. Are magic mushrooms next?


 

In Oregon and Denver, where marijuana is legal for recreational use, activists are now pushing toward a psychedelic frontier: “magic mushrooms.”

Groups in both states are sponsoring ballot measures that would eliminate criminal penalties for possession of the mushrooms whose active ingredient, psilocybin, can cause hallucinations, euphoria and changes in perception. They point to research showing that psilocybin might be helpful for people suffering from depression or anxiety.

“We don’t want individuals to lose their freedom over something that’s natural and has health benefits,” said Kevin Matthews, the campaign director of Denver for Psilocybin, the group working to decriminalize magic mushrooms in Colorado’s capital.


The recent failure of a nationally publicized campaign to decriminalize hallucinogenic mushrooms in California may not portend well for the psilocybin advocates in Oregon and Denver – though their initiatives are more limited than California’s.

The proposal in the Golden State would have decriminalized sales and transportation of magic mushrooms, not just possession. The proposed Denver measure would apply only to that city, while in Oregon mushroom use would be allowed only with the approval of a physician and under the supervision of a registered therapist.

None of the proposed initiatives envisions fully legalizing psilocybin mushrooms, which would allow the government to regulate and tax sales in a similar fashion to medical and recreational marijuana.

In Oregon, advocates face a steep climb to qualify their measure for the ballot, because such statewide initiatives typically require hiring paid signature gatherers, said William Lunch, a political analyst for Oregon Public Broadcasting and a former political science professor at Oregon State University.

Pages

Recommended Reading

Ketamine formulation study is ‘groundbreaking’
MDedge Internal Medicine
Hidradenitis suppurativa packs mighty QOL impact
MDedge Internal Medicine
Anticholinergics’ link to dementia calls for vigilance in elderly
MDedge Internal Medicine
VIDEO: National suicide hotline could result from pending U.S. law
MDedge Internal Medicine
Targeting inactivity, mood, and cognition could be key to reducing OA mortality
MDedge Internal Medicine
Suicidality assessment of people with autism needs better tools
MDedge Internal Medicine
Commentary: Shifting the care delivery paradigm to diabetes-depression collaborative care models
MDedge Internal Medicine
MDedge Daily News: How to handle opioid constipation
MDedge Internal Medicine
Comorbidities provide possible path to schizophrenia subtypes
MDedge Internal Medicine
U.S. public largely ignores firearm access and suicide completion link
MDedge Internal Medicine